Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NR-SAFE: a Safety Study Investigating Treatment With High-dose Nicotinamide Riboside (NR) in Parkinson's Disease

NCT05344404 is registered in ClinicalTrials.gov with Haukeland University Hospital as lead sponsor.

NCT NCT05344404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05344404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NR-SAFE: a Safety Study Investigating Treatment With High-dose Nicotinamide Riboside (NR) in Parkinson's Disease
Lead sponsor
Haukeland University Hospital
Phase
Not applicable
Overall status
Completed
Start date
April 29, 2022
Completion date
July 1, 2022
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease